In randomized controlled trials, There are 2 treatment solutions at present considered the common of treatment in Guillain-Barré syndrome (GBS). These involve possibly intravenous immunoglobulin (IVIG) or plasma https://ksnr.org.in/guillain-barre-syndrome/